- Home
- / Cannara Biotech
Cannara Biotech
Stock Price
$0.1
2021-05-12
Market Capitalization
$104.2 M
2021-05-12
Revenue
$107.3 M
FY, 2025
Cannara Biotech Summary
Company Summary
- Overview
- Cannara Biotech is a company that operates an indoor cannabis cultivation and processing facility. It aims to develop an infrastructure enabling the delivery of cannabis and cannabis-infused products for the Canadian and international markets.
- Type
- Public
- Status
- Active
- Founded
- 2018
- HQ
- Montréal, CA | view all locations
- Website
- https://www.cannara.ca/
- Cybersecurity rating
Table of Contents
Key People
Nicholas Sosiak, Chief Financial Officer
David Abitbol, VP Marketing
Noémi Follain, VP Finance
LocationsView all
1 location detected
Montréal, QC HQ
Canada
333 Décarie, Suite 200
Cannara Biotech Financials
Summary Financials
- Revenue (Q2, 2026)
- $C27.1M
- Gross profit (Q2, 2026)
- $C17.5M
- Net income (Q2, 2026)
- $C1.7M
- Cash (Q2, 2026)
- $C21.9M
- EBIT (Q2, 2026)
- $C3.3M
- Enterprise value
- $116.3M